Camden Capital »

Ascendis Pharma A S shares owned by Camden Capital

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Ascendis Pharma A S

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Camden Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $270k 2.1k 125.94

More positions owned by Camden Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Wisdomtree Tr Floatng Rat Trea (USFR)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Exxon Mobil Corporation (XOM)
General Electric Com New (GE)
New York Community Ban (NYCB)
Citigroup Com New (C)
Micron Technology (MU)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Core S&p500 Etf (IVV)
Morgan Stanley Com New (MS)
Chevron Corporation (CVX)
Bank of America Corporation (BAC)
Spdr S&p Midcap 400 Etf Tr Utser1 S&pdcrp (MDY)

View all positions for Camden Capital

Top funds holding Ascendis Pharma A S

RA Capital Management
Artisan Partners Limited Partnership
FMR
Westfield Capital Management Company
Henderson Group
venBio Select Advisor
Wellington Management Company
T. Rowe Price Investment Management
Franklin Resources
T. Rowe Price Associates
Massachusetts Financial Services
Sofinnova Ventures
Brown Advisory Holdings Incorporated
Spyglass Capital Management
Alliancebernstein

View all funds holding Ascendis Pharma A S